6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Internet Gaming Disorder and Behavioral Addictions
Internet Gaming Disorder (IGD) represents a growing concern in behavioral addictions, characterized by compulsive gaming that interferes with daily life. Like substance addictions, IGD involves dopamine dysregulation, reinforcing reward-seeking behaviors. Symptoms include withdrawal, tolerance, and neglect of personal responsibilities. Cognitive-behavioral therapy (CBT) is a cornerstone of treatment, focusing on behavior modification and identifying underlying psychological triggers. Family-based interventions and digital detox strategies are also effective in promoting balanced technology use. Understanding IGD as a legitimate addiction enables clinicians to provide targeted interventions, fostering healthier relationships with technology and reducing its negative impact on mental health.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States